Clinical trials
Completed Phase 1/2 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 2 |
| M.D. Anderson Cancer Center | 2 |
| AIO-Studien-gGmbH | 1 |
| Acrotech Biopharma Inc. | 1 |
| Celldex Therapeutics | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hoffmann-La Roche | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Immuneering Corporation | 1 |
| Imugene Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 23 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 6 |
| Neoplasms | 6 |
| Neoplasm Metastasis | 4 |
| Pancreatic Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.